$45.610
-0.643 (-1.41%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
NVO Prediction & Forecast by Similar Chart Analysis
Alphio's NVO stock price prediction model matches the current Novo Nordisk A/S tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $45.41 (-0.43%). The 1-week path is $48.78 (+6.96%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Novo Nordisk A/S Stock?
Novo Nordisk is not a good buy right now due to recent downgrades and declining performance metrics. The current price is $45.61, and the stock has seen a year-to-date change of -12.94%. Additionally, the RSI is at 38.59, indicating that the stock is nearing oversold territory but has not yet shown signs of recovery. The main risk is the downgrade from Deutsche Bank, which highlights concerns over future growth and a potential further decline in sales forecasts, with expected sales dropping from DKK 309 billion in 2025 to DKK 299 billion in 2026.
NVO stock price ended at $45.61 on Friday, after losing -1.41%
Novo Nordisk A/S (NVO) last closed at $45.61, losing -1.41%. These facts feed the 1-day and 1-week NVO price prediction above.
Analyst Consensus
Novo Nordisk A/S (NVO): 0 buy, 1 hold, 0 sell. Outlook: Hold.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Novo Nordisk A/S (NVO) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches NVO, ranked by similarity.
Seasonality analysis for NVO
Historically the probability of a positive August return for NVO is 34.92%. January offers the highest probability of a positive month at 67.21%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for NVO
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $81.07 | $83.84 | $85.16 | +83.82% |
| Sep 2026 | $74.51 | $86.43 | $101.91 | +89.51% |
| Oct 2026 | $80.81 | $91.03 | $96.90 | +99.58% |
| Nov 2026 | $83.51 | $89.42 | $100.21 | +96.06% |
| Dec 2026 | $73.30 | $84.65 | $87.35 | +85.61% |
In 2026, Novo Nordisk A/S (NVO) is projected to range from $73.30 to $101.91.
Novo Nordisk A/S 2026 monthly forecast
In Aug 2026, Novo Nordisk A/S is projected to average $83.84, with a low of $81.07 and high of $85.16.
In Sep 2026, Novo Nordisk A/S is projected to average $86.43, with a low of $74.51 and high of $101.91.
In Oct 2026, Novo Nordisk A/S is projected to average $91.03, with a low of $80.81 and high of $96.90.
In Nov 2026, Novo Nordisk A/S is projected to average $89.42, with a low of $83.51 and high of $100.21.
In Dec 2026, Novo Nordisk A/S is projected to average $84.65, with a low of $73.30 and high of $87.35.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。